Regional expression of dopamine D1 and D2 receptor proteins in the cerebral cortex of asphyxic newborn infants

Journal of Child Neurology

Volumn 24, Issue 2, 2009, Pages 183-193

  Kaewsuk, Sukit ^a   Tannenberg, Rudi K ^b   Kuo Sheng Wen, S W ^b   Björkman, S Tracey ^c   Govitrapong, Piyarat ^a   Stadlin, Alfreda ^c   Dodd, Peter R ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

Author keywords

Asphyxia; Autopsy; Dopamine; Perinatal; Receptor protein; Stress response

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR;

ANIMAL CELL; ARTICLE; AUTOPSY; BRAIN CORTEX LESION; BRAIN HYPOXIA; CONTROLLED STUDY; DYING; FEMALE; FRONTAL CORTEX; FROZEN SECTION; GESTATION PERIOD; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INFANT; MALE; MOTOR CORTEX; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; OCCIPITAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STRESS; TEMPORAL CORTEX; WESTERN BLOTTING;

ASPHYXIA NEONATORUM; BLOTTING, WESTERN; CEREBRAL CORTEX; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; INFANT, PREMATURE; MULTIVARIATE ANALYSIS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REGRESSION ANALYSIS;

EID: 59649110042     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073808322669     Document Type: Article

References (54)

1. Finer NN, Robertson CM, Richards RT, Pinnell LE, Peters KL Hypoxic-ischemic encephalopathy in term neonates: Perinatal factors and outcome. J Pediatr. 1981;98:112-117.
2. Hill A. Current concepts of hypoxic-ischemic cerebral injury in the term newborn. Pediatr Neurol. 1991;7:317-325.
3. Andersen DL, Tannenberg AEG, Burke CJ, Dodd PR Developmental rearrangements of cortical glutamate-NMDA receptor binding sites in late human gestation. Brain Res Dev Brain Res. 1995;88:178-185.
4. Vannucci RC, Voorhies TM Perinatal cerebral hypoxia-ischemia: pathogenesis and neuropathology. In: Sarnatt HB, ed. Topics in Neonatal Neurology. New York, NY: Grune & Stratton; 1984:27-59.
5. Duffy TE, Kohle SJ, Vannucci RC Carbohydrate and energy metabolism in perinatal rat brain: Relation to survival in anoxia. J Neurochem. 1975;24:271-276.
6. Hattori H., Wasterlain CG Excitatory amino acids in the developing brain: Ontogeny, plasticity, and excitotoxicity. Pediatr Neurol. 1990;6:219-228.
7. Mansour A., Meador-Woodruff JH, Zhou QY, Civelli O., Akil H., Watson SJ A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience. 1991;45:359-371.
8. Brene S., Hall H., Lindefors N., Karlsson P., Halldin C., Sedvall G. Distribution of messenger RNAs for D1 dopamine receptors and DARPP-32 in striatum and cerebral cortex of the cynomolgus monkey: Relationship to D1 dopamine receptors. Neuroscience. 1995;67:37-48.
9. Lidow MS, Goldman-Rakic PS, Gallager DW, Rakic P. Distribution of dopaminergic receptors in the primate cerebral cortex: Quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390. Neuroscience. 1991;40:657-671.
10. Worsley JN, Moszczynska A., Falardeau P., et al. Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users. Mol Psychiatry. 2000;5:664-672.
11. Brana C., Caille I., Pellevoisin C., et al. Ontogeny of the striatal neurons expressing the D1 dopamine receptor in humans. J Comp Neurol. 1996;370:23-34.
12. Brana C., Aubert I., Charron G., Pellevoisin C., Bloch B. Ontogeny of the striatal neurons expressing the D2 dopamine receptor in humans: An in situ hybridization and receptor-binding study. Brain Res Mol Brain Res. 1997;48:389-400.
13. Unis AS Ontogeny of [3H]-SCH23390 and [3H]-YM09151-2 binding sites in human fetal forebrain. Biol Psychiatry. 1994;35:562-569.
14. Hunt R., Osborn D. Dopamine for prevention of morbidity and mortality in term newborn infants with suspected perinatal asphyxia. Cochrane Database Syst Rev. 2002:CD003484.
15. Kapucu LO, Koc E., Gucuyener K., et al. D2 receptor imaging with iodine123-iodobenzamide brain SPECT in infants with hypoxic-ischemic brain injury. J Nucl Med. 1998;39:1703-1707.
16. Dodd PR, Hardy JA, Baig EB, et al. Optimization of freezing, storage, and thawing conditions for the preparation of metabolically active synaptosomes from frozen rat and human brain. Neurochem. Pathol. 1986;4:177-198.
17. Hynd MR, Lewohl JM, Scott HL, Dodd PR Biochemical and molecular studies using human autopsy brain tissue. J Neurochem. 2003;85:543-562.
18. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ Protein measurement with the Folin-phenol reagent. J Biol Chem. 1951;193:265-275.
19. Laemmli UK Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
20. Winer BJ, Brown DR, Michels KM Statistical Principles in Experimental Design. 3rd ed. Sydney, NSW, Australia: McGraw-Hill; 1991.
21. Lynch M., Walsh B. Genetics and Analysis of Quantitative Traits. Sunderland, MA: Sinauer Associates Inc; 1998.
22. Free RB, Hazelwood LA, Cabrera DM, et al. D1 and D2 dopamine receptor expression is regulated by direct interaction with the chaperone protein calnexin. J Biol Chem. 2007;282:21285-21300.
23. Bottiger BW, Schmitz B., Wiessner C., Vogel P., Hossmann KA Neuronal stress response and neuronal cell damage after cardiocirculatory arrest in rats. J Cereb Blood Flow Metab. 1998;18:1077-1087.
24. Laptook AR, Corbett RJ, Sterett R., Burns DK, Tollefsbol G., Garcia D. Modest hypothermia provides partial neuroprotection for ischemic neonatal brain. Pediatr Res. 1994;35:436-442.
25. Fraccaro M., Lindsten J., Ford CE, Iselius L. The 11q;22q translocation: a European collaborative analysis of 43 cases. Hum Genet. 1980;56:21-51.
26. Schinzel A., Schmid W., Auf der Maur P., et al. Incomplete trisomy 22. I. Familial 11/22 translocation with 3:1 meiotic disjunction. Delineation of a common clinical picture and report of nine new cases from six families. Hum Genet. 1981;56:249-262.
27. Iselius L., Lindsten J., Aurias A., et al. The 11q;22q translocation: A collaborative study of 20 new cases and analysis of 110 families. Hum Genet. 1983;64:343-355.
28. Katafuchi Y., Hashino K., Maeno Y., et al. Partial trisomy 22 with Dandy-Walker malformation. Acta Paediatr Jpn. 1990;32:566-570.
29. Velagaleti GV, Morgan DL, Tonk VS Trisomy 5p. A case report and review. Ann Genet. 2000;43:143-145.
30. Di Chiara G. Alcohol and dopamine. Alcohol Health Res World. 1997;21:108-114.
31. Ray R., Cooper PJ, Sim R., et al. Direct in situ reverse transcriptase polymerase chain reaction for detection of measles virus. J Virol Methods. 1996;60:1-17.
32. Jackson DM, Westlind-Danielsson A. Dopamine receptors: Molecular biology, biochemistry and behavioural aspects. Pharmacol Ther. 1994;64:291-370.
33. Tupala E., Tiihonen J. Dopamine and alcoholism: Neurobiological basis of ethanol abuse. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:1221-1247.
34. Kebabian JW, Calne DB Multiple receptors for dopamine. Nature. 1979;277:93-96.
35. Stoof JC, Kebabian JW Two dopamine receptors: Biochemistry, physiology and pharmacology. Life Sci. 1984;35:2281-2296.
36. Boyson SJ, Adams CE D1 and D2 dopamine receptors in perinatal and adult basal ganglia. Pediatr Res. 1997;41:822-831.
37. Gurevich EV, Kordower J., Joyce JN Dopamine D2 receptor mRNA is expressed in maturing neurons of the human hippocampal and subicular fields. Neuroreport. 1997;8:3605-3610.
38. Gurevich EV, Kordower JH, Joyce JN Ontogeny of the dopamine D2 receptor mRNA expressing cells in the human hippocampal formation and temporal neocortex. J Chem Neuroanat. 2000;20:307-325.
39. Barks JD, Silverstein FS, Sims K., Greenamyre JT, Johnston MV Glutamate recognition sites in human fetal brain. Neurosci Lett. 1988;84:131-136.
40. Represa A., Tremblay E., Ben-Ari Y. Transient increase of NMDA-binding sites in human hippocampus during development. Neurosci Lett. 1989;99:61-66.
41. Benfenati F., Cimino M., Zoli M., Grimaldi R., Zini I., Agnati LF Decrease in mRNA levels but not in the density of D2 dopamine receptors in rat striatum after transient forebrain ischemia. Neurosci Lett. 1991;126:6-8.
42. Adair J., Filloux F. Effects of hypoxic-ischemic brain damage on dopaminergic markers in the neonatal rat: A regional autoradiographic analysis. J Child Neurol. 1992;7:199-207.
43. Kostic VS, Przedborski S., Jackson-Lewis V., Cadet JL, Burke RE Effect of unilateral perinatal hypoxic-ischemic brain injury on striatal dopamine uptake sites and D1 and D2 receptors in adult rats. Neurosci Lett. 1991;129:197-200.
44. Przedborski S., Kostic V., Jackson-Lewis V., Cadet JL, Burke RE Effect of unilateral perinatal hypoxic-ischemic brain injury in the rat on dopamine D1 and D2 receptors and uptake sites: A quantitative autoradiographic study. J Neurochem. 1991;57:1951-1961.
45. Filloux F., Adair J., Narang N. The temporal evolution of striatal dopamine receptor binding and mRNA expression following hypoxia-ischemia in the neonatal rat. Brain Res Dev Brain Res. 1996;94:81-91.
46. Gross J., Muller I., Chen Y., et al. Perinatal asphyxia induces region-specific long-term changes in mRNA levels of tyrosine hydroxylase and dopamine D(1) and D(2) receptors in rat brain. Brain Res Mol Brain Res. 2000;79:110-117.
47. Meng SZ, Isumi H., Takashima S. Neuropathological characteristics and alteration of the dopamine D2 receptor in hypoxic-ischemic basal ganglia necrosis. Brain Dev. 1998;20:98-104.
48. Bozzi Y., Borrelli E. Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it? Trends Neurosci. 2006;29:167-174.
49. Kitamura Y., Kakimura J., Taniguchi T. Antiparkinsonian drugs and their neuroprotective effects. Biol Pharm Bull. 2002;25:284-290.
50. Schapira AH Neuroprotection and dopamine agonists. Neurology. 2002;58:S9-S18.
51. O'Neill MJ, Hicks CA, Ward MA, et al. Dopamine D2 receptor agonists protect against ischæmia-induced hippocampal neuro-degeneration in global cerebral ischaemia. Eur J Pharmacol. 1998;352:37-46.
52. Sawada H., Ibi M., Kihara T., et al. Dopamine D2-type agonists protect mesencephalic neurons from glutamate neurotoxicity: Mechanisms of neuroprotective treatment against oxidative stress. Ann Neurol. 1998;44:110-119.
53. Kihara T., Shimohama S., Sawada H., et al. Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade. J Neurosci Res. 2002;70:274-282.
54. Iida M., Miyazaki I., Tanaka K., Kabuto H., Iwata-Ichikawa E., Ogawa N. Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist. Brain Res. 1999;838:51-59.